Business

Cryosite : Confirmation of Release - CTE - Appendix 4E and Annual Report - 23 August 2017

Cryosite : Confirmation of Release - CTE - Appendix 4E and Annual Report - 23 August

Cryosite LimitedAugust 23, 20175
Cryosite : Confirmation of Release - CTE - Appendix 4E and Annual Report - 23 August 2017

About this update from Cryosite Limited

Cryosite Limited ABN 86 090 919 476 Appendix 4E Full year report 0B Results for announcement to the market Details of Reporting Period The financial information contained in this report is for the year ended 30 June 2017. Comparative amounts (unless otherwise indicated) relate to the year ended 30 June 2016. $A'000 2.1 Revenue from ordinary activities: Up 0.3% to 10,163 2.2 Profit from ordinary activities after tax attributable to members: Down 25.5% to 225 2.3 Net profit for the period attributable to members: Down 25.5% to 225 R esults for Announcement to the Market Dividends The Board of Cryosite has recommended that no dividends be paid. Commentary on the results to the market The audited annual accounts are attached. Please refer to these for full results and commentary. 1B 5. NTA backing Current period Previous corresponding Period Net tangible asset backing per ordinary security 5.6 cents 6.0 cents 8 CRYOSITE LIMITED ABN 86 090 919 476 Ann ual Report for the year ended 30 June 2017 Table of Contents Corporate Information Page Directors' Report 2 Auditor's Independence Decla ration 17 Corporate Governance Statement 18 Directors' Decla ration 19 Consolidated Statement of Comprehensive Income 20 Consolidated Statement of Financial Position 21 Consolidated Statement of Changes in Equity 22 Consolidated Statement of Cash Flow 23 Notes to the Financial Statements l Corporate Information 24 Summary of Significant Accounting Policies 24 Significant Accounting Judgements, Estimates and Assumptions 35 Segment Information 37 Revenue 38 Expenses 38 Income Tax 39 Earnings Per Share 40 Dividends Paid and Proposed 41 Cash and Cash Equivalents 41 Cash Flow Statement Reconciliation 42 Current Assets - Trade and Other Receivables 42 Current Assets - Inventories 43 Current Assets - Prepayments 43 Non-Current - Trade and Other Receivables 44 Non-Current Assets - Investments in Subsidiaries 44 Non-Current Assets - Plant and Equipment 45 Non-Current Assets - Intangible Assets 46 Trade and Other Payables 48 Current Liabilities - Unearned Income 48 Non-Current Liabilities - Unearned Income 48 Non-Current Liabilities -Provisions 49 Contributed Equity and Accumulated Losses 50 Reserves 51 Commitments and Contingencies 51 Events After Balance Date 52 Auditors' Remuneration 52 Related Party Disclosures 52 Shared-Based Payments Expens e 53 Key Management Personnel 55 Financial Instruments 56 Parent Entity Financial Information 59 Independent Audit Report 61 ASX Additional Shareholder Information 65 CRYOSITE LIMITED - ANNUAL REPORT Corporate Information AHN 86 090 919 476 DIRECTORS Mr. Stephen Roberts (Non-Executive Chair) Mr. Andrew Kroger (Non-Executive Director) Mrs Nicola Swift (Non-Executive Director) COMPANY SECRETARY Mr . Bryan Dulhunty (CoSA Life Science - Corporate) REGISTERED OFFICE AND PRINCIPAL PLACE OF BUSINESS l 3a Ferndell Street SOUTH GRANVILLE NSW 2142 Telephone: +61 2 8865 2000 Fax: +61 2 8865 2090 Email : c orporat e@c r y o s it e . c om SHARE REGISTER Link Market Services Limited Level 8, 580 George Street SYDNEY NSW, 2000 Telephone : +61 2 8260 7111 AUDITORS Mazars Risk & Assurance Pty Limited Level 12, 90 Arthur Street NORTH SYDNEY NSW , 2060 T e lephone : +61 2 9922 1166 INTERNET ADDRESS www.cryo s ite . com ww w .cryos it ese r y ic es.c om

View stock analysis, news, and events for Cryosite Limited

More from Cryosite Limited

All Cryosite Limited news →